Age has been reported as a risk factor for glioma [46], patients with IDH mutations have a better prognosis [47], patients with the 1p19q codel have a better prognosis [48,49], and MGMT methylated patients are more sensitive to treatment with TMZ [50,51]. This evidence concerns the gene MGMT and glioma.